Efgartigimod
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for Efgartigimod, covering 2020-09-14 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis [Phase 2, Phase 3]